LBL - Given what little we've heard from AMRN "management" so far, appeal seems to be the path. I agree, this thing is not going anywhere pps wise for a long time. Just like the old days.
Larry I have to agree with you. It was one thing waiting for R-I results (where many of us had at least an inkling that the study would work) but to now wait 2 or 3 years for something that has much less than 50% chance of success seems silly. That is compounded by the fact that money tied up in Amarin can now be moved to other stocks who have been decimated this last month or two and offer at little more of a better chance of rising without having everything weighing on the outcome of another trial.